Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 669 of 5804
-
New diabetes drug shows promise for teens in landmark trial
Disease control CompletedThe purpose of this study is to learn more about the safety and efficacy of tirzepatide compared to placebo in children or teenagers with type 2 diabetes taking metformin, or basal insulin, or both. The overall study will last about 60 weeks with up to 14 clinic visits and 6 pho…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could storing your own stem cells shield bone marrow during cancer treatment?
Disease control Recruiting nowThe aim of this project is to promote the reconstruction of haematopoietic function after chemoradiotherapy for cervical cancer with the innovative use of autologous haematopoietic containing stem cell blood transfusion support.To explore the effect of stored hemopoietic stem cel…
Phase: NA • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a 4-Month TB cocktail replace the standard 6-Month cure?
Disease control CompletedThis trial will assess the safety and efficacy of OPC-167832 combined with delamanid and bedaquiline in participants with drug-susceptible tuberculosis (DS-TB) administered for 17 weeks compared to rifampin, isoniazid, ethambutol, pyrazinamide (RHEZ) administered for 26 weeks.
Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
ER program aims to curb opioid use and keep patients in treatment
Disease control OngoingCollaborative care is a comprehensive patient-centered model of healthcare delivery targeting behavioral health or substance use that stems from the chronic disease management framework. The intervention being tested ('Emergency Department Longitudinal Integrated Care' or ED LINC…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug combo targets hard-to-treat lung cancer mutation
Disease control OngoingThis study will assess the safety and efficacy of avutometinib (VS-6766) in combination with sotorasib with or without defactinib in patients with KRAS G12C Non-Small Cell Lung Cancer (NSCLC) in patients who have been exposed to prior G12C inhibitor and those who have not been ex…
Phase: PHASE1, PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy shows promise for tough-to-treat liver cancer
Disease control CompletedHepatic artery infusion chemotherapy (HAIC) and anti-programmed cell death protein-1ligand (PD-L1) immunotherapy have shown promising outcomes in patients with advanced hepatocellular carcinoma (HCC), respectively. However, the combination of the two treatments has not been repor…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New bladder cancer treatment delivers drug straight to the tumor
Disease control Recruiting nowThe purpose of the study in Part 1 (dose escalation) and in Part 2 (dose expansion) is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) and evaluate preliminary clinical efficacy. Part 3 (dose expansion) will confirm safety and preliminary clinical activity at the RP2D. P…
Phase: PHASE1, PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a vaccine stop pancreatic cancer before it starts?
⭐️ VACCINE ⭐️ Recruiting nowThis Phase 1 study will evaluate safety and the immune response to pooled mutant-KRAS peptide vaccine with poly-ICLC adjuvant for patients who have been identified to be at risk of developing pancreatic cancer.
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 02, 2026 00:00 UTC
-
Experimental antibody takes on tough bile duct cancers
Disease control OngoingThis is a single-arm, phase II clinical trial to evaluate the efficacy of XmAb20717 in patients with advanced biliary tract cancers who have progressed on, or were intolerant of, a gemcitabine-based chemotherapy regimen.
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 26, 2026 17:01 UTC
-
New vaccine combo shows promise in advanced cancers
Disease control CompletedA Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with pembrolizumab, as First-line Treatment for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of Head or Neck (SCCHN), or Metastatic Urot…
Phase: PHASE2 • Sponsor: IO Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Boosting transplants with natural killers: new combo therapy aims to stop blood cancer return
Disease control CompletedThe goal of this clinical research study is to learn about the safety and effectiveness of giving KDS-1001 in combination with a standard stem cell transplant to patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML). KDS-100…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Blood test could spot lung cancer early in smokers
Diagnosis OngoingCASCADE-LUNG is a multisite, prospective, observational, blood specimen collection study in the elevated-risk lung cancer screening population. The primary objective is to demonstrate the performance characteristics, including sensitivity, specificity, positive predictive value (…
Sponsor: Delfi Diagnostics Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
New targeted therapy combo shows promise for HER2+ breast cancer
Disease control OngoingThis phase Ib/II trial studies the side effects and best dose of ribociclib, tucatinib, and trastuzumab for the treatment of HER2 positive breast cancer that has spread to other parts of the body (metastatic), and then compares the effect of ribociclib, tucatinib, trastuzumab wit…
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Ketamine may shield patients from PTSD after critical care
Disease control ENROLLING_BY_INVITATIONThe RSI-LTO study collects long-term outcomes from the RSI trial (NCT05277896). One-third of adults who are intubated in the ED or ICU experience symptoms of posttraumatic stress disorder (PTSD). PTSD is a psychiatric disorder triggered by a "shocking, scary, or dangerous event."…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Sound waves vs. prostate cancer: new trial aims to zap tumors without surgery
Disease control Recruiting nowThis clinical trial tests whether the magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) procedure is safe and effective in treating patients with low to intermediate grade prostate cancer. MRI-guided TULSA ablation is a minimally invasive procedure…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a poop pill lift depression and soothe IBS?
Disease control OngoingThis study is a phase 2/3 open-label controlled trial (CT) in which adults with Major Depressive Disorder (MDD) and adults who have MDD plus comorbid Inflammatory Bowel Syndrome (IBS) will be assigned to either receive oral Fecal Microbiota Transplantation (FMT) or to continue wi…
Phase: PHASE2, PHASE3 • Sponsor: Valerie Taylor • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug combo aims to outsmart Treatment-Resistant head and neck cancer
Disease control Recruiting nowThis multicenter, open-label, randomized phase 3 trial will determine if palbociclib and cetuximab (Arm 1) improves overall survival (OS) in comparison to cetuximab monotherapy (Arm 2) in patients with CDKN2A-altered, HPV-unrelated recurrent or metastatic head and neck squamous c…
Phase: PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New radioactive antibody treatment shows promise for childhood brain cancer
Disease control OngoingA Phase 2 study investigating the addition of cRIT 131I-omburtamab to irinotecan, temozolomide, and bevacizumab for patients with recurrent medulloblastoma. A feasibility cohort is included to assess the feasibility of incorporating cRIT 131I-omburtamab for patients with recurren…
Phase: PHASE2 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Pregnant women with hepatitis c get new hope from 12-Week drug trial
Disease control OngoingThis is a multicenter, single arm study of Sofosbuvir/Velpatasvir (SOF/VEL) for treatment of chronic hepatitis C infection during pregnancy. Treatment will be initiated during the second or third trimester in approximately 100 pregnant people. Maternal participants will take one …
Phase: PHASE4 • Sponsor: Catherine Anne Chappell • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a quick brain zap ease suicidal thoughts in depressed teens?
Symptom relief CompletedThe purpose of this study is to gather information regarding the use of a new type of transcranial magnetic stimulation (TMS) called theta burst stimulation (TBS) for suicidal ideation in adolescents with Major Depressive Disorder (MDD). The investigators hope to learn if this TM…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC